Skip Navigation

JNCI Journal of the National Cancer Institute 2003 95(18):1358-1359; doi:10.1093/jnci/95.18.1358
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Schultz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schultz, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2003 Oxford University Press

NEWS

Data From DNA Repair Studies Questioned As Leading Researcher Investigated

James Schultz

The first 10% of the full text of this article appears below.

Because science depends on collaboration and experimental replication, even the slightest hint of fraud or neglect reverberates quickly throughout the scientific community. Such is the case with Steven A. (Tony) Leadon, Ph.D., considered by his colleagues a leading authority in the field of transcription-coupled DNA repair (TCR). Leadon has been accused of falsifying data related to the repair function of the BRCA1 protein and how BRCA1 absence or modification is associated with a higher incidence of breast and ovarian cancers.

The accusations may lead to the recall of several major papers on which Leadon was a co-author, and may force researchers to reverify previous . . . [Full Text of this Article]

Colleague Response

BRCA Work


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?